CD200 is induced by ERK and is a potential therapeutic target in melanoma

Immune-mediated antitumor responses occur in patients with metastatic melanoma (MM), and therapies designed to augment such responses are clinically beneficial. Despite the immunogenicity of melanoma, immunomodulatory therapies fail in the majority of patients with MM. An inability of DCs to suffici...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Petermann, Kimberly B., Rozenberg, Gabriela I., Zedek, Daniel, Groben, Pamela, McKinnon, Karen, Buehler, Christin, Kim, William Y., Shields, Janiel M., Penland, Shannon, Bear, James E., Thomas, Nancy E., Serody, Jonathan S., Sharpless, Norman E.
Формат: Artigo
Язык:Inglês
Опубликовано: American Society for Clinical Investigation 2007
Предметы:
Research Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2075477/
https://ncbi.nlm.nih.gov/pubmed/18008004
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI32163
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы